CORAL LABORATORIES
|
The Current P/E Ratio of CORAL LABORATORIES is 9.66.
Share Price | ₹480.9 | Aug 20,2025 |
Market Cap | ₹173.1 Cr | |
Earnings-TTM | ₹17.9 Cr | TTM-Standalone Results |
Price/Earnings | 9.66x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CORAL LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹173.1 Cr] as on Aug 20,2025
(/) Earnings [ ₹17.9 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 9.66x ]
Thus, for CORAL LABORATORIES , the investors are currently willing to pay 9.66 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CORAL LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CORAL LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of CORAL LABORATORIES
PE Ratio Performance Analysis for CORAL LABORATORIES
- CORAL LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.91x.
- CORAL LABORATORIES 's operated at median p/e ratio of 8.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CORAL LABORATORIES 's p/e ratio peaked in Mar2023 at 12.69x.
- CORAL LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 4.91x.
How does CORAL LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CORAL LABORATORIES | 17.92 | 9.66 | 173.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.67 | 392,195.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.13 | 159,417.0 |
CIPLA LTD | 5,406.81 | 23.09 | 124,867.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.92 | 123,971.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.15 | 103,956.0 |
MANKIND PHARMA LTD | 1,905.51 | 54.27 | 103,413.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.33 | 98,917.8 |
LUPIN LTD | 3,722.18 | 23.81 | 88,627.2 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.77 | 60,751.9 |
ABBOTT INDIA LTD | 1,452.29 | 47.72 | 69,310.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CORAL LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 9.66x |
Max industry PE | 69.13x |
Median industry PE | 23.81x |
Average industry PE | 34.96x |
You may also like the below Video Courses